The essential role of histone acetylation in CRPC phenotype is further supported by other fundamental observations showing that inhibitors of p300/CBP acetyltransferases inhibited the AR-mediated transcriptional progress in both AR-sensitive and AR-resistant prostate cancer cells and tumor growth in a CFRPC xenograft model [656,657]. The gene discussed is AR; the disease is prostate carcinoma.